Alzheimer’s Society responds to the letter from the Secretary of State for Health and Social Care to Baroness Casey of Blackstock DBE CB detailing commitments to dementia.
In collaboration with the UK Dementia Trials Network (UKDTN), Alzheimer’s Society will embed dedicated Dementia Research Nurses in key NHS clinical settings across the UK. Find out more about the team below.
Early trial results appear to suggest that new drug donanemab slows the progression of Alzheimer’s symptoms by 36%.
An extract from Mary-Joy Albutt’s blog on why she decided to trek across the Sahara for Alzheimer’s Society in memory of her Mum who lived with dementia for 12 years.
Dementia Support Line